A Path Back to Health: Immune Tolerance to Infectious Disease

Most infectious disease research focuses on the battle between host and pathogen. While an individual’s abilities to resist infection and combat microbes are important, this process is only half of the story.

In this month's episode, Niki Spahich from The Scientist’s Creative Services team spoke with David Schneider, professor of microbiology and immunology at Stanford University, to learn why it is crucial to consider how organisms tolerate disease, and to explore how he maps the paths individuals take through infection and back to health.

The Scientist Speaks is a podcast produced by The Scientist’s Creative Services team. Our podcast is by scientists and for scientists. Once a month, we will bring you the stories behind news-worthy molecular biology research. This month's episode is supported by MilliporeSigma.


David Schneider, PhD
Microbiology and Immunology
Stanford University



MilliporeSigma is a leading company for innovative, trusted products for genomic and protein sample prep, reliable antibodies, proteins and enzymes, advanced cell culture, and lab water solutions. They provide researchers with best-in-class technologies, expertise, and services to accelerate discovery, including extensively validated Prestige Antibodies®, now offered in convenient small pack sizes. Explore more at SigmaAldrich.com/Prestige.

Listen Now


Information you provide will be held in confidence and will be shared with the sponsoring vendor(s) of this podcast. We may use the information to contact you about your account and to let you know about related programs and products; you may opt-out at any time. This allows The Scientist to keep these podcasts free of charge for our readers.